
Organic Process Research and Development p. 670 - 685 (2020)
Update date:2022-08-04
Topics:
Hardouin, Christophe
Baillard, Sandrine
Barière, Fran?ois
Craquelin, Anthony
Grandjean, Mathieu
Janvier, Solenn
Le Roux, Stéphane
Penloup, Christine
Russo, Olivier
This paper describes the synthesis of kilogram quantities of the sulfonamide moiety 3 involved in a coupling reaction with acid moiety 2 to provide batches of drug candidate 1 for preclinical studies and first-in-human clinical trials. A first approach relying on a chiral separation furnished the desired enantiomer of 1,3-diamine 20, precursor of sulfonamide 3. An enantiomeric synthesis of 20 using the Ellman's chiral auxiliary coupled with an aza-Reformatsky reaction to control the stereochemistry is also discussed. Coupling conditions of the final step involving EDCI to provide 1 under a cGMP process are detailed. An alternative approach using N-(1-methanesulfonyl)benzotriazole is also presented.
View Morewebsite:http://www.afinechem.com
Contact:+86-571-85134551
Address:No. 206 Zhen Hua Road, Hangzhou 310030, Zhejiang, China
Contact:+86-13666670345
Address:Agricultural Development Zone, Haining, Jiaxing, Zhejiang
Contact:+44 (0)161 367 9441
Address:
Lanling Hongchuang Flame Retardant Co., Ltd.
Contact:+86-531-68858132
Address:East Huafeichang Road, Cangshan County, Linyi, Shandong, China (Mainland)
Nanjing Chemipioneer Pharma&Tech Co.,Ltd
website:http://www.chemipioneer.com.cn
Contact:+86-25-52685700
Address:Room 305,A Block,Biological-Medicine Building,Business Start-up Center,Xin-ke 1st Road, High-tech development zone,Nanjing city,Jiangsu Province, China
Doi:10.1016/j.jorganchem.2008.04.023
(2008)Doi:10.1016/S0040-4039(00)95115-3
(1985)Doi:10.1039/c39860000757
(1986)Doi:10.1002/chem.201501823
(2015)Doi:10.1039/c1gc15701a
(2011)Doi:10.1002/jhet.5570450420
(2008)